Neda Mostajeran | Pharmaceutical Science Award | Best Researcher Award

Dr. Neda Mostajeran | Pharmaceutical Science Award | Best Researcher Award

Dr. Neda Mostajeran, Mashhad University of Medical Sciences, Iran

Dr. Neda Mostajeran is a Ph.D. candidate in Pharmaceutical Nanotechnology at Mashhad University of Medical Sciences, Iran. Her research focuses on innovative drug delivery systems including nanoliposomes, hydrogels, and nanofibers for applications in cancer therapy, wound healing, and ocular diseases. She has expertise in nanoformulations like liposomes and polymers, coupled with skills in tissue engineering and biochemical assays. With a background in Organic Chemistry and a strong publication record, she explores cutting-edge therapies such as non-coding RNA-based treatments. Driven by a passion for advancing healthcare through nanotechnology, she excels in scientific research, statistical analysis, and technical writing. 🧬


Publication profile

Professional Background

Dr. Neda Mostajeran is currently pursuing her Ph.D. in Pharmaceutical Nanotechnology at Mashhad University of Medical Sciences, Iran. Her research spans diverse areas including drug delivery systems, nano sensors, and hydrogel manufacturing, particularly focusing on nanoliposomes. She investigates factors influencing angiogenesis in cancer, wound healing, and ocular diseases, alongside exploring tissue engineering techniques for scaffold design like hydrogels and nanofibers. Her work extends to modern therapeutic nanosystems and the development of beads for localized osteomyelitis treatment. Proficient in MTT assay and HPLC, Dr. Mostajeran is dedicated to advancing nano-based drug delivery formulations such as liposomes, micelles, and polymers, with expertise in in-vitro biochemical and immunological assays. πŸ§ͺ

Educational Achievements


Dr. Mostajeran holds a Master’s degree in Organic Chemistry from Islamic Azad University and a Bachelor’s in Chemistry from Kashan University. She possesses additional skills in statistical analysis, technical writing, communication, teaching, RT-PCR, and cell culture. πŸ“š


Research Focus

Dr. Neda Mostajeran’s research primarily focuses on the design, solvent-free synthesis, and evaluation of antibacterial activity of coumarin sulfonamides. Her work, published in reputable journals like the Journal of the Iranian Chemical Society and Pharmaceutical Chemistry Journal, showcases her expertise in pharmaceutical chemistry and nanotechnology. Dr. Mostajeran collaborates extensively with peers on innovative approaches to synthesizing bioactive compounds and assessing their therapeutic potential, particularly in combating bacterial infections. Her contributions underscore a commitment to advancing drug discovery methodologies, integrating nanotechnology with organic chemistry to develop novel compounds that address significant health challenges. πŸ§ͺ


Publication Top Notes

Xintian Shao | Pharmaceutical Science Award | Best Researcher Award

Dr. Xintian Shao | Pharmaceutical Science Award | Best Researcher Award

Dr. Xintian Shao, Shandong First Medical University & Shandong Academy of Medical Sciences, China

Dr. Xintian Shao earned her PhD in Microbiology and Biochemical Pharmacy from Shandong University, China, under the guidance of Prof. Peixue Ling. She expanded her expertise as a Visiting Scholar in Cancer Biology at the University of Cincinnati, USA, mentored by Prof. Jiajie Diao. Currently serving as an Associate Professor at Shandong First Medical University, her research has yielded 10 impactful publications and secured numerous grants. With two patents to her name, she’s been honored with prestigious awards including the Shandong Medical Science and Technology Award and the Science and Technology Award of Shandong Pharmaceutical Association.


Publication ProfileΒ 


Education and Academic Achievements πŸ“šπŸ…

Dr. Xintian Shao completed her PhD in Microbiology and Biochemical Pharmacy at the School of Pharmacy, Shandong University, China, under the guidance of Prof. Peixue Ling. She further enriched her expertise as a visiting scholar in Cancer Biology at the University of Cincinnati, USA, mentored by Prof. Jiajie Diao. Her prolific research has resulted in 10 publications, including notable contributions to journals such as Advanced Drug Delivery Reviews and Advanced Science. With multiple patents and prestigious grants to her credit, she has earned recognition including the Shandong Medical Science and Technology Award (2021) and the Science and Technology Award of Shandong Pharmaceutical Association (2022).

Work Experience πŸ’Ό

Dr. Xintian Shao has served as an Associate Professor at the School of Life Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, China. Her role involves not only teaching and mentorship but also continued research contributions in her field.

Research Focus

Dr. Xintian Shao’s research primarily focuses on subcellular imaging and targeted drug delivery systems. Her work delves into the intricate dynamics of organelle interactions, particularly within mitochondria and lysosomes, employing cutting-edge super-resolution imaging techniques. She explores novel methods for visualizing drug molecules within living organisms, enhancing our understanding of drug distribution and efficacy. With a keen interest in membrane biology and organelle-specific targeting, her contributions shed light on fundamental cellular processes and hold promise for advancements in drug delivery and therapeutics.

Publication Top NotesΒ 

  1. “Single-organelle localization-based super-resolution imaging for subcellular molecules micro-dynamics” by Fang, G. et al., Coordination Chemistry Reviews, 2024.
  2. “Enhanced optical imaging and fluorescent labeling for visualizing drug molecules within living organisms” by Sun, T. et al., Acta Pharmaceutica Sinica B, 2024.
  3. “Mitochondrial nucleoid condensates drive peripheral fission through high membrane curvature” by Chen, Q. et al., Cell Reports, 2023.
    Cited by: 1
  4. “Graphene Oxide Nanosheets Induce Mitochondrial Fragmentation by Cutting through Membrane” by Shao, X. et al., ACS Materials Letters, 2023.
    Cited by: 4
  5. “Subcellular visualization: Organelle-specific targeted drug delivery and discovery” by Shao, X. et al., Advanced Drug Delivery Reviews, 2023.
    Cited by: 7
  6. “Recent advances in fluorescent probes of peroxynitrite: Structural, strategies and biological applications” by Sun, J. et al., Theranostics, 2023.
    Cited by: 8
  7. “Single Image Capture of Bioactive Ion Crosstalk within Inter-Organelle Membrane Contacts at Nanometer Resolution” by Fang, G. et al., Small Methods, 2022.
    Cited by: 8
  8. “Lysosome-Targeted Biosensor for the Super-Resolution Imaging of Lysosome–Mitochondrion Interaction” by Wang, H. et al., Frontiers in Pharmacology, 2022.
    Cited by: 4
  9. “Super-resolution image-based tracking of drug distribution in mitochondria of a label-free naturally derived drug molecules” by Wei, Y. et al., Chemical Engineering Journal, 2022.
    Cited by: 19
  10. “Prefused lysosomes cluster on autophagosomes regulated by VAMP8” by Chen, Q. et al., Cell Death and Disease, 2021.
    Cited by: 24



Alessandra Bitto | Pharmaceutical Science | Most Cited Paper Award

Prof Dr. Alessandra Bitto | Pharmaceutical Science | Most Cited Paper Award

Prof Dr. Alessandra Bitto, University of Messina, Italy

πŸ‘©β€πŸ”¬ Prof. Alessandra Bitto, born on August 26, 1979, in Messina, Italy, is a distinguished figure in medical research. Graduating with top honors (110/110 cum laude) in Medicine and Surgery from the University of Messina in 2003, her early career was marked by groundbreaking research on neointimal hyperplasia. Dr. Bitto’s contributions have been recognized globally, earning prestigious awards like the Young Researcher Award and the SIF Award for her work on postmenopausal metabolic syndrome. She has presented her findings at international symposiums, notably in Tokyo, Japan, showcasing her expertise on the effects of genistein aglycone. With a penchant for exploration, Dr. Bitto has enriched her knowledge through educational stints across Europe and the USA, delving into diverse fields from molecular biology to neuroscience. Her dedication to advancing medical science is evident in her role as a Visiting Researcher at renowned institutions like the University of Kentucky. Dr. Alessandra Bitto continues to inspire with her passion for research and her commitment to improving global health.

Publication Profile:



Google Scholar


πŸŽ“ Dr. Alessandra Bitto, born and raised in Messina, Italy, embarked on her academic journey by pursuing a degree in Medicine and Surgery at the University of Messina. Throughout her university career, she delved into various disciplines, from human anatomy and physiology to pathology and pharmacology. Her dedication to understanding the intricacies of medical science led her to specialize in pharmacology at the Department of Experimental Clinic of Medicine and Pharmacology. Graduating with top honors in July 2003, her research thesis on the role of MAPK ERK and JNK in neointimal hyperplasia garnered widespread acclaim, laying the foundation for her remarkable contributions to the field.



πŸ† Dr. Alessandra Bitto’s contributions to medical science have been widely recognized through numerous awards and accolades. In 2008, she clinched the prestigious Young Researcher Award from the University of Messina, applauding her outstanding scientific productivity. Her groundbreaking research on the effects of phytoestrogen genistein in postmenopausal metabolic syndrome earned her the SIF Award for the best poster at a national seminar in Pharmacology. Invitations as a keynote speaker at international symposiums further highlighted her expertise, notably in Tokyo, Japan. Her excellence was reaffirmed with the Young Investigator Award for her pioneering work on genistein aglycone’s role in managing secondary osteoporosis, culminating in the SIF-Farmindustria Award in 2009. 🌟



🌍 Dr. Alessandra Bitto’s global academic pursuits have enriched her knowledge and expertise in various fields. From delving into histology at the University of Santiago de Compostela, Spain, to exploring molecular biology in Vienna, Austria, her foreign educational experiences have been diverse and extensive. She further broadened her horizons in infectious diseases at Aarhus University, Denmark, and cardiovascular research at the University of Helsinki, Finland. Her journey continued with immersive experiences in molecular genetics at the University of Barcelona, Spain. Notably, she expanded her insights into neurosciences at the Medical University of South Carolina and cardiovascular research at the University of Kentucky in the USA, solidifying her as a globally renowned researcher. 🌟


Research Focus:

πŸ”¬ Dr. Alessandra Bitto’s research focus lies at the intersection of oxidative stress, inflammation, and therapeutic interventions for various health conditions. Her extensive body of work spans across multiple domains, including cardiovascular health, bone metabolism, and wound healing. With a particular emphasis on the effects of phytoestrogens, she has explored their potential in mitigating postmenopausal symptoms and managing metabolic syndrome. Additionally, her studies on erythropoietin’s angiogenic properties and the cholinergic anti-inflammatory pathway highlight her dedication to understanding the mechanisms underlying tissue repair and inflammation modulation. Dr. Bitto’s diverse research endeavors continue to shed light on novel therapeutic strategies for improving human health. πŸ”πŸŒ±

Publication Top Notes:




Kavitha Jayaseelan | Pharmaceutical Science | Best Faculty Award

Dr. Kavitha Jayaseelan | Pharmaceutical Science | Best Faculty Award

Dr. Kavitha Jayaseelan, SRM COLLEGE OF PHARMACY, India

πŸŽ“ Kavitha Jayaseelan is an accomplished educator with 12+ years of experience, currently serving as Associate Professor at SRM College of Pharmacy. With expertise in Bio-analytical Method Development and Validation, she holds a Ph.D. from SRM Institute of Science and Technology. Kavitha is dedicated to enhancing student learning and has received accolades such as the Best Teacher Award by SIMATS. Her proactive involvement in university agendas, coupled with her role as a reviewer for esteemed journals, underscores her commitment to academic excellence. Passionate about research, she continually seeks to empower young minds and contribute to the field of pharmaceutical analysis. πŸ“š

Publication Profile:




πŸŽ“ Kavitha Jayaseelan embarked on her academic journey with a Bachelor of Pharmacy from SRM College of Pharmacy, securing a merit seat and graduating with distinction in 2006. She furthered her studies with a Master of Pharmacy in Pharmaceutical Analysis from JSS College of Pharmacy, again earning a merit seat and achieving distinction in 2009. Driven by her passion for research, Kavitha pursued a Ph.D. in Pharmacy at SRM College of Pharmacy, SRM Institute of Science and Technology, completing her doctoral studies from 2012 to 2018. Her academic excellence and dedication to the field of pharmacy shine through her educational accomplishments. πŸ“š


πŸ… Kavitha Jayaseelan’s career is adorned with notable achievements and accolades. She was honored with the Best Interactive Speaker Award at the 2nd Global Virtual Summit on Pharmaceutical & Novel Drug Delivery Systems in Rome, Italy, in March 2023. Recognized for her exceptional teaching prowess, Kavitha clinched the Best Teacher Award by SIMATS – Global Iconic Excellence Award in August 2022. As a respected academic, she serves as a reviewer for esteemed journals like Critical Reviews in Analytical Chemistry. Her academic brilliance is underscored by gold medals in her Master of Pharmacy program and recognition from the IPA Nilgiris branch. πŸŽ–οΈ

Industrial Experience:

πŸ’Ό Kavitha Jayaseelan gained valuable industrial experience as a Trainee Chemist at Retort Pharmaceuticals Pvt. Ltd., where she worked in Quality Control from September 2006 to June 2007. This stint provided her with practical insights into pharmaceutical manufacturing processes and quality assurance protocols. Immersed in the pharmaceutical industry, Kavitha honed her skills in ensuring product quality and compliance with regulatory standards. Her time in this role equipped her with hands-on experience that complemented her academic pursuits, enriching her understanding of real-world applications in pharmaceutical analysis. This industrial exposure further strengthened her expertise and commitment to excellence in her field. 🏭

Training Experience:

πŸŽ“ Kavitha Jayaseelan underwent specialized training at CADRAT, JSS College of Pharmacy, focusing on Bio-analytical method development and Bioequivalence studies from April 2008 to February 2009. This immersive training provided her with in-depth knowledge and practical skills in the critical areas of pharmaceutical analysis. Engaging in bio-analytical method development and bioequivalence studies equipped Kavitha with the expertise needed to analyze pharmaceutical compounds and ensure their efficacy and safety. This training experience augmented her academic foundation, empowering her to contribute meaningfully to the advancement of pharmaceutical research and development. Kavitha’s dedication to continuous learning and professional development is evident through her pursuit of specialized training opportunities. πŸ“š

Research Focus:

πŸ”¬ Kavitha Jayaseelan’s research focus lies primarily in analytical and bioanalytical techniques for pharmaceutical quantification. Her extensive contributions to various journals underscore her expertise in spectrophotometric and chromatographic methods for drug analysis, including UV spectrophotometry and HPLC. Kavitha’s research encompasses diverse areas such as method development and validation, multivariate calibration techniques, and applications in pharmaceutical formulations. Her dedication to advancing analytical chemistry is evident through her comprehensive exploration of drug quantification methodologies, aiming to enhance accuracy and efficiency in pharmaceutical analysis. Through her research endeavors, Kavitha endeavors to contribute significantly to the pharmaceutical industry’s quality control and drug development processes. πŸ§ͺ

Publication Top Notes:




Anand Kumar | Pharmaceutical Science | Best Researcher Award

Mr. Anand Kumar | Pharmaceutical Science | Best Researcher Award

Mr. Anand Kumar, Babasaheb Bhimrao Ambedkar University Lucknow, India

πŸŽ“ Dr. Anand Kumar is a dedicated researcher and educator with a profound academic background. He holds a Ph.D. in Pharmaceutical Sciences, specializing in areas like Cancer Biology, Muscle Biology, and Sarcopenia. An alumnus of prestigious institutions such as Babasaheb Bhimrao Ambedkar University and Chhatrapti Shahu Ji Maharaj University, Dr. AnandKumar has been honored with fellowships from Indian Council of Medical Research and University Grants Commission. His commitment to advancing pharmaceutical knowledge is underscored by his multiple qualifications and extensive research experience. With a passion for understanding and combating diseases, he represents a beacon of excellence in the field. πŸ…

Publication Profile:


Google Scholar

Education Qualifications:

πŸŽ“ Dr. AnandKumar’s educational journey is marked by a series of impressive accomplishments and a steadfast pursuit of excellence in pharmaceutical sciences. His academic odyssey began with an Intermediate degree in Physics, Chemistry, and Maths from the UP Board, where he attained a commendable first-class score. Venturing further into the realm of pharmacy, he obtained a D. Pharm from Sarojini Naidu Medical College, Agra, demonstrating his early dedication to the field. Undeterred by challenges, he pursued a B. Pharm from Chhatrapti Shahu Ji Maharaj University, Kanpur, and later, an M. Pharm in Pharmacology from Babasaheb Bhimrao Ambedkar University, Lucknow, where he consistently achieved first-class distinctions.His academic journey culminated in a significant milestone with a Ph.D. in Pharmaceutical Sciences from the same institution, where his thesis was submitted in July 2023. Dr. AnandKumar’s relentless pursuit of knowledge and his commitment to academic excellence are evident in his consistent academic achievements. Through his rigorous academic training, he has honed his expertise in areas such as pharmacology and pharmaceutical sciences, paving the way for impactful contributions to the field. Dr. AnandKumar’s educational trajectory exemplifies resilience, dedication, and a profound passion for advancing pharmaceutical research and practice. 🌟

Honors, Recognition, and Awards:

πŸ… Dr. AnandKumar’s contributions to pharmaceutical research have been recognized through prestigious honors and awards. In 2022, he was bestowed with the Indian Council of Medical Research (ICMR) Senior Research Fellowship (SRF) by the Ministry of Health and Family Welfare, Government of India, acknowledging his exceptional research prowess. Prior to this, he received the PGSPROF Fellowship from the University Grants Commission (UGC) between 2016 and 2018, further affirming his dedication to academic excellence. Additionally, Dr. AnandKumar’s exemplary performance is underscored by his remarkable achievement of qualifying the Graduate Pharmacy Aptitude Test (GPAT) five times between 2017 and 2023, highlighting his commitment to continuous learning and proficiency in pharmaceutical sciences. 🌟

Professional Experience:

πŸ‘¨β€πŸ« Dr. AnandKumar’s professional journey includes both teaching and research experiences, shaping him into a well-rounded pharmaceutical scientist. His teaching tenure spans six months, during which he imparted knowledge and mentored students in various aspects of pharmacy. Complementing his role in academia, Dr. AnandKumar has amassed valuable research experience in diverse domains. Through his engagement in research, he has delved into intricate subjects such as Cancer Biology, Muscle Biology, and Sarcopenia, contributing significantly to the advancement of pharmaceutical sciences. His dual expertise in teaching and research reflects his commitment to academic excellence and his passion for pushing the boundaries of scientific inquiry. πŸ“šπŸ”¬

Research Focus:

πŸ”¬ Dr. Anand Kumar’s research focus encompasses a broad spectrum of pharmaceutical sciences, with a particular emphasis on combating various aspects of muscle biology-related disorders. His work delves into elucidating mechanisms underlying skeletal muscle wasting conditions such as sarcopenia, diabetic muscle atrophy, and muscle damage induced by diverse factors. Through innovative approaches including pharmacological interventions and targeted drug delivery systems, he aims to mitigate muscle wasting and associated inflammatory responses. Dr. AnandKumar’s multidisciplinary research endeavors, as evidenced by his publications, contribute significantly to understanding and addressing the complexities of muscle-related pathologies, paving the way for novel therapeutic strategies in the field. 🌟

Publication Top Notes:

Novel synergistic approach: tazarotene-calcipotriol-loaded-PVA/PVP-nanofibers incorporated in hydrogel film for management and treatment of psoriasis

Azilsartan Ameliorates Skeletal Muscle Wasting in High Fat Diet (HFD)-induced Sarcopenic Obesity in Rats via Activating Akt Signalling Pathway

Salbutamol ameliorates skeletal muscle wasting and inflammatory markers in streptozotocin (STZ)-induced diabetic rats

Vinpocetine mitigates DMH-induce pre-neoplastic colon damage in rats through inhibition of pro-inflammatory cytokines

Salbutamol Attenuates Diabetic Skeletal Muscle Atrophy by Reducing Oxidative Stress, Myostatin/GDF-8, and Pro-Inflammatory Cytokines in Rats

Atenolol Ameliorates Skeletal Muscle Atrophy and Oxidative Stress Induced by Cast Immobilization in Rats

Evaluation Of Azilsartan Transdermal Hydrogel In Volumetric Muscle Loss Injury In A Rat Model

Investigating the Role of Angiotensin Receptor Blockers (ARBs) In High Fat Diet-Induced Sarcopenic Rats Associated Muscle Wasting

Pentapeptide cRGDfK-Surface Engineered Nanostructured Lipid Carriers as an Efficient Tool for Targeted Delivery of Tyrosine Kinase Inhibitor for Battling Hepatocellular Carcinoma